CH621342A5 - - Google Patents
Download PDFInfo
- Publication number
- CH621342A5 CH621342A5 CH1073075A CH1073075A CH621342A5 CH 621342 A5 CH621342 A5 CH 621342A5 CH 1073075 A CH1073075 A CH 1073075A CH 1073075 A CH1073075 A CH 1073075A CH 621342 A5 CH621342 A5 CH 621342A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- pharmaceutically acceptable
- radical
- alkoxy
- benzene ring
- Prior art date
Links
- -1 hydroxy- Chemical group 0.000 claims description 62
- 150000001875 compounds Chemical class 0.000 claims description 50
- 150000003839 salts Chemical class 0.000 claims description 28
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 23
- 238000002360 preparation method Methods 0.000 claims description 20
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 claims description 16
- 239000003054 catalyst Substances 0.000 claims description 10
- 125000004494 ethyl ester group Chemical group 0.000 claims description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 229910052783 alkali metal Inorganic materials 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 238000005984 hydrogenation reaction Methods 0.000 claims description 4
- ACKFDYCQCBEDNU-UHFFFAOYSA-J lead(2+);tetraacetate Chemical compound [Pb+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O ACKFDYCQCBEDNU-UHFFFAOYSA-J 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 101150047265 COR2 gene Proteins 0.000 claims description 3
- 101100467189 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) QCR2 gene Proteins 0.000 claims description 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- BLFJCJKTSCOLEY-UHFFFAOYSA-N cinnoline-3-carboxylic acid Chemical compound C1=CC=C2N=NC(C(=O)O)=CC2=C1 BLFJCJKTSCOLEY-UHFFFAOYSA-N 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- VUXPLVKFGQNRHS-UHFFFAOYSA-N ethyl 6-chlorocinnoline-3-carboxylate Chemical compound ClC1=CC=C2N=NC(C(=O)OCC)=CC2=C1 VUXPLVKFGQNRHS-UHFFFAOYSA-N 0.000 claims description 3
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical compound O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 claims description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 3
- 150000003254 radicals Chemical class 0.000 claims description 3
- BKWQKVJYXODDAC-UHFFFAOYSA-N 1,2-dihydropyridazine Chemical group N1NC=CC=C1 BKWQKVJYXODDAC-UHFFFAOYSA-N 0.000 claims description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- 125000006501 nitrophenyl group Chemical group 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 125000006678 phenoxycarbonyl group Chemical group 0.000 claims description 2
- DGQOCLATAPFASR-UHFFFAOYSA-N tetrahydroxy-1,4-benzoquinone Chemical compound OC1=C(O)C(=O)C(O)=C(O)C1=O DGQOCLATAPFASR-UHFFFAOYSA-N 0.000 claims description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- KKFDJZZADQONDE-UHFFFAOYSA-N (hydridonitrato)hydroxidocarbon(.) Chemical compound O[C]=N KKFDJZZADQONDE-UHFFFAOYSA-N 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 claims 1
- 150000002823 nitrates Chemical class 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 99
- 239000000203 mixture Substances 0.000 description 67
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 51
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 42
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 26
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 26
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- 238000010992 reflux Methods 0.000 description 21
- 239000007787 solid Substances 0.000 description 20
- 239000000706 filtrate Substances 0.000 description 14
- 239000007858 starting material Substances 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000003208 petroleum Substances 0.000 description 11
- 230000002829 reductive effect Effects 0.000 description 11
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 238000009835 boiling Methods 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 239000012279 sodium borohydride Substances 0.000 description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 6
- CXUGAWWYKSOLEL-UHFFFAOYSA-N 2h-cinnolin-3-one Chemical compound C1=CC=C2N=NC(O)=CC2=C1 CXUGAWWYKSOLEL-UHFFFAOYSA-N 0.000 description 5
- 239000000377 silicon dioxide Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 150000001854 cinnolines Chemical class 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 3
- CFDSAJBDDOBOED-UHFFFAOYSA-N 6-bromocinnoline-3-carboxylic acid Chemical compound BrC1=CC=C2N=NC(C(=O)O)=CC2=C1 CFDSAJBDDOBOED-UHFFFAOYSA-N 0.000 description 3
- QBJULWPEGLVWGY-UHFFFAOYSA-N 6-phenylcinnoline-3-carboxylic acid Chemical compound C=1C=C2N=NC(C(=O)O)=CC2=CC=1C1=CC=CC=C1 QBJULWPEGLVWGY-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 125000000259 cinnolinyl group Chemical class N1=NC(=CC2=CC=CC=C12)* 0.000 description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 3
- HVTGTSYFNIEXKG-UHFFFAOYSA-N ethyl 6-aminocinnoline-3-carboxylate Chemical compound NC1=CC=C2N=NC(C(=O)OCC)=CC2=C1 HVTGTSYFNIEXKG-UHFFFAOYSA-N 0.000 description 3
- RPFGEDCRTBJBQQ-UHFFFAOYSA-N ethyl 6-bromocinnoline-3-carboxylate Chemical compound BrC1=CC=C2N=NC(C(=O)OCC)=CC2=C1 RPFGEDCRTBJBQQ-UHFFFAOYSA-N 0.000 description 3
- KOHOPCSEDPEAQQ-UHFFFAOYSA-N ethyl 6-ethyl-1,4-dihydrocinnoline-3-carboxylate Chemical compound C(C)C=1C=C2CC(=NNC2=CC1)C(=O)OCC KOHOPCSEDPEAQQ-UHFFFAOYSA-N 0.000 description 3
- AEZGOJOZPNPWRI-UHFFFAOYSA-N ethyl 6-nitrocinnoline-3-carboxylate Chemical compound [O-][N+](=O)C1=CC=C2N=NC(C(=O)OCC)=CC2=C1 AEZGOJOZPNPWRI-UHFFFAOYSA-N 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- HNBVGOCWUWBFBI-UHFFFAOYSA-N 6-cyclohexylcinnoline-3-carboxylic acid Chemical compound C=1C=C2N=NC(C(=O)O)=CC2=CC=1C1CCCCC1 HNBVGOCWUWBFBI-UHFFFAOYSA-N 0.000 description 2
- GVZLMHNNWAWJQF-UHFFFAOYSA-N 6-ethylcinnoline-3-carboxylic acid Chemical compound N1=NC(C(O)=O)=CC2=CC(CC)=CC=C21 GVZLMHNNWAWJQF-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- ZRXBOXOGGODVBV-UHFFFAOYSA-N ethyl 4-oxo-6-(phenylmethoxycarbonylamino)-1h-cinnoline-3-carboxylate Chemical compound C=1C2=C(O)C(C(=O)OCC)=NN=C2C=CC=1NC(=O)OCC1=CC=CC=C1 ZRXBOXOGGODVBV-UHFFFAOYSA-N 0.000 description 2
- TUGQSKBCJBVKRY-UHFFFAOYSA-N ethyl 6-(phenylmethoxycarbonylamino)cinnoline-3-carboxylate Chemical compound C=1C=C2N=NC(C(=O)OCC)=CC2=CC=1NC(=O)OCC1=CC=CC=C1 TUGQSKBCJBVKRY-UHFFFAOYSA-N 0.000 description 2
- YSOWMKXBIDUXBA-UHFFFAOYSA-N ethyl 6-bromo-4-oxo-1H-cinnoline-3-carboxylate Chemical compound C1=CC(Br)=CC2=C(O)C(C(=O)OCC)=NN=C21 YSOWMKXBIDUXBA-UHFFFAOYSA-N 0.000 description 2
- CQDHMEGGSXPPIN-UHFFFAOYSA-N ethyl 6-nitro-4-oxo-1h-cinnoline-3-carboxylate Chemical compound C1=CC([N+]([O-])=O)=CC2=C(O)C(C(=O)OCC)=NN=C21 CQDHMEGGSXPPIN-UHFFFAOYSA-N 0.000 description 2
- UNCCFELLDGQGCG-UHFFFAOYSA-N ethyl 6-phenylcinnoline-3-carboxylate Chemical compound C=1C=C2N=NC(C(=O)OCC)=CC2=CC=1C1=CC=CC=C1 UNCCFELLDGQGCG-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- SLINOLVLQJDNOR-UHFFFAOYSA-N 1,4-dihydrocinnoline Chemical class C1=CC=C2CC=NNC2=C1 SLINOLVLQJDNOR-UHFFFAOYSA-N 0.000 description 1
- UFMBERDMCRCVSM-UHFFFAOYSA-N 1h-cinnolin-4-one Chemical class C1=CC=C2C(O)=CN=NC2=C1 UFMBERDMCRCVSM-UHFFFAOYSA-N 0.000 description 1
- WKNOIMDWWMTXMF-UHFFFAOYSA-N 2-(diethylamino)ethyl 6-bromocinnoline-3-carboxylate Chemical compound BrC1=CC=C2N=NC(C(=O)OCCN(CC)CC)=CC2=C1 WKNOIMDWWMTXMF-UHFFFAOYSA-N 0.000 description 1
- ZYIFXLMEIVHSNY-UHFFFAOYSA-N 2-aminoethenone Chemical compound NC=C=O ZYIFXLMEIVHSNY-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- 229940013085 2-diethylaminoethanol Drugs 0.000 description 1
- NIVPIWAHGGDIMP-UHFFFAOYSA-N 2-ethoxyethyl 6-bromocinnoline-3-carboxylate Chemical compound BrC1=CC=C2N=NC(C(=O)OCCOCC)=CC2=C1 NIVPIWAHGGDIMP-UHFFFAOYSA-N 0.000 description 1
- OWMJPOIYLPPJGE-UHFFFAOYSA-N 6-bromo-4-oxo-1h-cinnoline-3-carboxylic acid Chemical compound C1=C(Br)C=C2C(=O)C(C(=O)O)=NNC2=C1 OWMJPOIYLPPJGE-UHFFFAOYSA-N 0.000 description 1
- XKRKKKYETXBCNZ-UHFFFAOYSA-N 6-bromocinnoline-3-carbonyl chloride Chemical compound BrC1=CC=C2N=NC(C(=O)Cl)=CC2=C1 XKRKKKYETXBCNZ-UHFFFAOYSA-N 0.000 description 1
- ATRQMCPOBZZRMQ-UHFFFAOYSA-N 6-butylcinnoline-3-carboxylic acid Chemical compound N1=NC(C(O)=O)=CC2=CC(CCCC)=CC=C21 ATRQMCPOBZZRMQ-UHFFFAOYSA-N 0.000 description 1
- RQPKPZSTIWQUAY-UHFFFAOYSA-N 6-chlorocinnoline-3-carboxylic acid Chemical compound ClC1=CC=C2N=NC(C(=O)O)=CC2=C1 RQPKPZSTIWQUAY-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 125000005083 alkoxyalkoxy group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229960003116 amyl nitrite Drugs 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- SULWBFBEODFBCH-UHFFFAOYSA-N benzyl 6-bromocinnoline-3-carboxylate Chemical compound C=1C2=CC(Br)=CC=C2N=NC=1C(=O)OCC1=CC=CC=C1 SULWBFBEODFBCH-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- IJSRLSPZAHLSHV-UHFFFAOYSA-N ethyl 4-chlorocinnoline-3-carboxylate Chemical compound C1=CC=CC2=C(Cl)C(C(=O)OCC)=NN=C21 IJSRLSPZAHLSHV-UHFFFAOYSA-N 0.000 description 1
- AGSPACXVRDJSQX-UHFFFAOYSA-N ethyl 6-(2-methoxyphenyl)-1,4-dihydrocinnoline-3-carboxylate Chemical compound C1=C2CC(C(=O)OCC)=NNC2=CC=C1C1=CC=CC=C1OC AGSPACXVRDJSQX-UHFFFAOYSA-N 0.000 description 1
- ZWAKSIZFDSMRCD-UHFFFAOYSA-N ethyl 6-(2-methoxyphenyl)cinnoline-3-carboxylate Chemical compound C=1C=C2N=NC(C(=O)OCC)=CC2=CC=1C1=CC=CC=C1OC ZWAKSIZFDSMRCD-UHFFFAOYSA-N 0.000 description 1
- SGSYFVWDSANBBN-UHFFFAOYSA-N ethyl 6-(4-chlorophenyl)-4-oxo-1H-cinnoline-3-carboxylate Chemical compound C=1C2=C(O)C(C(=O)OCC)=NN=C2C=CC=1C1=CC=C(Cl)C=C1 SGSYFVWDSANBBN-UHFFFAOYSA-N 0.000 description 1
- VQIHNEAKQMACIU-UHFFFAOYSA-N ethyl 6-(4-chlorophenyl)cinnoline-3-carboxylate Chemical compound C=1C=C2N=NC(C(=O)OCC)=CC2=CC=1C1=CC=C(Cl)C=C1 VQIHNEAKQMACIU-UHFFFAOYSA-N 0.000 description 1
- SYESXLNLQVNDEV-UHFFFAOYSA-N ethyl 6-amino-4-oxo-1h-cinnoline-3-carboxylate Chemical compound C1=CC(N)=CC2=C(O)C(C(=O)OCC)=NN=C21 SYESXLNLQVNDEV-UHFFFAOYSA-N 0.000 description 1
- TZYWZKIAKPXZQY-UHFFFAOYSA-N ethyl 6-bromo-4-chlorocinnoline-3-carboxylate Chemical compound C1=CC(Br)=CC2=C(Cl)C(C(=O)OCC)=NN=C21 TZYWZKIAKPXZQY-UHFFFAOYSA-N 0.000 description 1
- VJNVSQRAUWCRKY-UHFFFAOYSA-N ethyl 6-butylcinnoline-3-carboxylate Chemical compound N1=NC(C(=O)OCC)=CC2=CC(CCCC)=CC=C21 VJNVSQRAUWCRKY-UHFFFAOYSA-N 0.000 description 1
- VTSSEBZBUWNJQV-UHFFFAOYSA-N ethyl 6-ethylcinnoline-3-carboxylate Chemical compound CCC1=CC=C2N=NC(C(=O)OCC)=CC2=C1 VTSSEBZBUWNJQV-UHFFFAOYSA-N 0.000 description 1
- DSEVXZHUPSUCCP-UHFFFAOYSA-N ethyl 6-phenyl-1,4-dihydrocinnoline-3-carboxylate Chemical compound C1(=CC=CC=C1)C=1C=C2CC(=NNC2=CC1)C(=O)OCC DSEVXZHUPSUCCP-UHFFFAOYSA-N 0.000 description 1
- KYBPERFYKILZCL-UHFFFAOYSA-N ethyl 6-propylcinnoline-3-carboxylate Chemical compound N1=NC(C(=O)OCC)=CC2=CC(CCC)=CC=C21 KYBPERFYKILZCL-UHFFFAOYSA-N 0.000 description 1
- PHDNOFTVHXOAJB-UHFFFAOYSA-N ethyl 7-chlorocinnoline-3-carboxylate Chemical compound C1=C(Cl)C=C2N=NC(C(=O)OCC)=CC2=C1 PHDNOFTVHXOAJB-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- VGGSEGTTZDAXBR-UHFFFAOYSA-N methyl 6-methylcinnoline-3-carboxylate Chemical compound CC1=CC=C2N=NC(C(=O)OC)=CC2=C1 VGGSEGTTZDAXBR-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- CSDTZUBPSYWZDX-UHFFFAOYSA-N n-pentyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- GIXUBIHZIIGAMF-UHFFFAOYSA-N phenyl 6-ethylcinnoline-3-carboxylate Chemical compound C=1C2=CC(CC)=CC=C2N=NC=1C(=O)OC1=CC=CC=C1 GIXUBIHZIIGAMF-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3636074A GB1474399A (en) | 1974-08-19 | 1974-08-19 | Cinnolin-3-yl carboxylic acids and derivatives thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH621342A5 true CH621342A5 (no) | 1981-01-30 |
Family
ID=10387436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1073075A CH621342A5 (no) | 1974-08-19 | 1975-08-18 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4027023A (no) |
| JP (1) | JPS5143777A (no) |
| AR (1) | AR207476A1 (no) |
| AT (1) | AT344712B (no) |
| BE (1) | BE832412A (no) |
| CA (1) | CA1063114A (no) |
| CH (1) | CH621342A5 (no) |
| CS (1) | CS192518B2 (no) |
| DD (1) | DD123338A5 (no) |
| DE (1) | DE2536913A1 (no) |
| DK (1) | DK367675A (no) |
| ES (1) | ES440327A1 (no) |
| FI (1) | FI62665C (no) |
| FR (1) | FR2282273A1 (no) |
| GB (1) | GB1474399A (no) |
| HU (1) | HU172146B (no) |
| IE (1) | IE41643B1 (no) |
| IL (1) | IL47855A (no) |
| IN (1) | IN140439B (no) |
| LU (1) | LU73210A1 (no) |
| NL (1) | NL7509692A (no) |
| NO (1) | NO146672C (no) |
| PH (1) | PH14552A (no) |
| PL (1) | PL101804B1 (no) |
| SE (1) | SE415658B (no) |
| SU (1) | SU856382A3 (no) |
| ZA (1) | ZA754979B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4379929A (en) * | 1981-03-19 | 1983-04-12 | Eli Lilly And Company | 4(1H)-Oxocinnoline-3-carboxylic acid derivatives |
| US4557934A (en) | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| FR2549833B1 (fr) * | 1983-07-26 | 1985-11-08 | Roussel Uclaf | Derives de la pyrazolo /4,3-c/ cinnolin-3-one, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et produits intermediaires |
| GB8513639D0 (en) * | 1985-05-30 | 1985-07-03 | Ici America Inc | Cinnoline compounds |
| GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
| US4925844A (en) * | 1988-02-09 | 1990-05-15 | Ici Americas Inc. | Antagonizing the pharmacological effects of a benzodiazepine receptor agonist |
| US7700595B2 (en) | 2005-03-01 | 2010-04-20 | Wyeth Llc | Cinnoline compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH96A (de) * | 1889-01-18 | Von Derschau Albert | Vorrichtung an Handfeuerwaffen als Ersatz des Visirs, welche das Abfeuern nur dann gestattet, wenn die Waffe einen bestimmten Winkel mit der Horizontalen bildet | |
| US3657241A (en) * | 1970-03-12 | 1972-04-18 | Dow Chemical Co | Substituted cinnoline compounds |
| IE35662B1 (en) * | 1970-10-16 | 1976-04-14 | Ici Ltd | Pharmaceutical compositions |
-
1974
- 1974-08-19 GB GB3636074A patent/GB1474399A/en not_active Expired
-
1975
- 1975-01-01 AR AR260053A patent/AR207476A1/es active
- 1975-07-28 IE IE1682/75A patent/IE41643B1/en unknown
- 1975-07-28 CA CA232,341A patent/CA1063114A/en not_active Expired
- 1975-07-28 US US05/599,348 patent/US4027023A/en not_active Expired - Lifetime
- 1975-07-28 IN IN1476/CAL/1975A patent/IN140439B/en unknown
- 1975-08-01 ZA ZA00754979A patent/ZA754979B/xx unknown
- 1975-08-03 IL IL47855A patent/IL47855A/xx unknown
- 1975-08-13 BE BE159188A patent/BE832412A/xx not_active IP Right Cessation
- 1975-08-13 DK DK367675A patent/DK367675A/da not_active Application Discontinuation
- 1975-08-14 NL NL7509692A patent/NL7509692A/xx not_active Application Discontinuation
- 1975-08-15 PL PL1975182756A patent/PL101804B1/pl unknown
- 1975-08-18 FR FR7525529A patent/FR2282273A1/fr active Granted
- 1975-08-18 CS CS755649A patent/CS192518B2/cs unknown
- 1975-08-18 AT AT638275A patent/AT344712B/de not_active IP Right Cessation
- 1975-08-18 LU LU73210A patent/LU73210A1/xx unknown
- 1975-08-18 NO NO752864A patent/NO146672C/no unknown
- 1975-08-18 SE SE7509209A patent/SE415658B/xx unknown
- 1975-08-18 CH CH1073075A patent/CH621342A5/de not_active IP Right Cessation
- 1975-08-18 FI FI752332A patent/FI62665C/fi not_active IP Right Cessation
- 1975-08-18 SU SU752164732A patent/SU856382A3/ru active
- 1975-08-18 DD DD187917A patent/DD123338A5/xx unknown
- 1975-08-18 HU HU75IE00000708A patent/HU172146B/hu unknown
- 1975-08-19 ES ES440327A patent/ES440327A1/es not_active Expired
- 1975-08-19 JP JP50100571A patent/JPS5143777A/ja active Pending
- 1975-08-19 DE DE19752536913 patent/DE2536913A1/de not_active Ceased
- 1975-08-30 PH PH17481A patent/PH14552A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1063114A (en) | 1979-09-25 |
| CS192518B2 (en) | 1979-08-31 |
| AR207476A1 (es) | 1976-10-08 |
| FI62665B (fi) | 1982-10-29 |
| NO146672B (no) | 1982-08-09 |
| ES440327A1 (es) | 1977-03-01 |
| NL7509692A (nl) | 1976-02-23 |
| IE41643L (en) | 1976-02-19 |
| FR2282273A1 (fr) | 1976-03-19 |
| SE7509209L (sv) | 1976-02-20 |
| FI62665C (fi) | 1983-02-10 |
| LU73210A1 (no) | 1977-01-07 |
| JPS5143777A (no) | 1976-04-14 |
| AU8351175A (en) | 1977-02-03 |
| NO146672C (no) | 1982-11-17 |
| IE41643B1 (en) | 1980-02-27 |
| ATA638275A (de) | 1977-12-15 |
| IN140439B (no) | 1976-11-13 |
| DE2536913A1 (de) | 1976-03-04 |
| HU172146B (hu) | 1978-06-28 |
| IL47855A0 (en) | 1975-11-25 |
| DD123338A5 (no) | 1976-12-12 |
| PH14552A (en) | 1981-09-24 |
| NO752864L (no) | 1976-02-20 |
| SU856382A3 (ru) | 1981-08-15 |
| BE832412A (fr) | 1976-02-13 |
| SE415658B (sv) | 1980-10-20 |
| ZA754979B (en) | 1976-10-27 |
| AT344712B (de) | 1978-08-10 |
| FI752332A (no) | 1976-02-20 |
| DK367675A (da) | 1976-02-20 |
| GB1474399A (en) | 1977-05-25 |
| US4027023A (en) | 1977-05-31 |
| IL47855A (en) | 1979-07-25 |
| FR2282273B1 (no) | 1978-11-10 |
| PL101804B1 (pl) | 1979-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2749518A1 (de) | Benzamidderivate | |
| CH615152A5 (en) | Process for the preparation of carboxylic acid amides and the carboxylic acid amides thus prepared | |
| DE2751181A1 (de) | Neue therapeutika auf piperidinbasis | |
| DE1795613A1 (de) | Indolylessigsaeuren,Verfahren zu ihrer Herstellung und Arzneipraeparate | |
| DE2846931C2 (no) | ||
| CH621342A5 (no) | ||
| DD289526A5 (de) | Neue chemische prozesse | |
| CH631973A5 (de) | Verfahren zur herstellung von benzimidazolderivaten. | |
| EP0224159B1 (de) | Neue basisch substituierte Pyridinverbindungen, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel und ihre Verwendung | |
| DE1919381A1 (de) | Heterocyclische Verbindungen und Verfahren zu deren Herstellung | |
| CH619213A5 (en) | Process for the preparation of carbazole derivatives | |
| DE2431292A1 (de) | Neue carbazol-derivate | |
| DE2550179A1 (de) | Cinnolinderivate | |
| CH624400A5 (no) | ||
| DE1470116C3 (de) | N(I Arylalkyl 4 pipendyl)-anilide und Verfahren zu ihrer Herstellung | |
| AT165073B (de) | Verfahren zur Darstellung substituierten Piperido-octahydrophenanthrenen | |
| AT278787B (de) | Verfahren zur herstellung von neuen carbonsaeuren und von deren salzen | |
| AT218519B (de) | Verfahren zur Herstellung von neuen Pyrazol-Derivaten | |
| AT242873B (de) | Verfahren zur Herstellung von Testosteron-17-chloral-halbacetalestern | |
| AT234102B (de) | Verfahren zur Herstellung von neuen, in α-Stellung durch einen 1-Benzylindolyl-(3)-Rest substituierten niedrigen aliphatischen Säuren | |
| AT222116B (de) | Verfahren zur Herstellung von neuen, 4-substituierten 1,2-Diaryl-3,5-dioxo-pyrazolidinen | |
| AT241452B (de) | Verfahren zur Herstellung neuer 2-Acyl-Derivate des 5-Amino-isoindolins | |
| AT234678B (de) | Verfahren zur Herstellung von neuen Pyrazolidin-3,5-dion-Derivaten | |
| AT228218B (de) | Verfahren zur Herstellung von neuen Thioxanthen-Verbindungen | |
| EP0000574A1 (de) | Benzimidazol-2-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |